Gelatin

Gelatin is known as coating agent, film-forming agent, gelling agent, suspending agent, tablet binder, viscosity-increasing agent.. This product is available in Arvin Kala’s diverse product portfolio.

Description
Gelatin appears as a light amber to faint yellow, glassy, brittle solid. It is nearly odorless and tasteless, and can be found in the form of translucent sheets, flakes, granules, or coarse powder.
Applications in Pharmaceutical Formulation or Technology

Gelatin is extensively used in various pharmaceutical formulations, including as a biodegradable matrix material in implantable delivery systems. However, its most common application is in the production of hard or soft gelatin capsules.
Gelatin capsules are unit-dosage forms primarily intended for oral administration. Soft capsules are also available for rectal and vaginal use. Hard capsules can be filled with solids (such as powders, granules, pellets, tablets, and their mixtures), as well as semisolid and liquid fillings. In contrast, soft capsules are mainly filled with semisolid or liquid substances. In hard capsules, the active drug is always part of the filling, whereas in soft capsules, the drug can also be incorporated into the thick capsule shell.
Gelatin dissolves in warm water (above 30°C), causing the capsule to swell and eventually dissolve in gastric fluid, releasing its contents rapidly.
Hard capsules are produced in two parts by dipping lubricated stainless steel mold pins into a gelatin solution heated to 45 to 55°C. The viscosity of the solution, which varies based on the capsule size and whether the cap or body is being formed, determines the film thickness. The gelatin adheres to the pins through gelation, and the resulting film thickness is controlled by the solution’s viscosity. The capsule shells are then passed through a stream of cool air to set the gelatin, followed by slow drying with large volumes of humidity-controlled air heated slightly above ambient temperature, blown directly over the pins. The capsule halves are then removed from the pins, trimmed, and assembled.
Gelatin used for hard capsules may include various coloring agents and antimicrobial preservatives. Small quantities of surfactants may also be present in the shells as residues from the pin lubricant. However, the use of preservatives is now discouraged in accordance with current GMP principles. Capsule shells can be treated with formaldehyde to make them insoluble in gastric fluid. Standard capsules range in volume from 0.13 to 1.37 mL. For veterinary use, capsules with volumes between 3 and 28 mL are available, and capsules with a capacity of 0.025 mL are available for toxicity studies in rats.
Unlike two-piece hard capsules, soft gelatin capsules are manufactured, filled, and sealed in a single process. The gelatin used for soft shells has a lower gel strength and viscosity compared to that used for hard capsules, resulting in more flexible shells. Soft shell formulations include plasticizers such as polyalcohols (glycerin, propylene glycol, polyethylene glycol). Sorbitol can be added as a moisturizing agent, with the additional water acting as a plasticizer. Coloring and opacifying agents are also incorporated.
The filling can chemically interact with the gelatin and plasticizer, potentially causing migration of filling components into the shell and vice versa. These interactions must be considered during the formulation of both the gelatin shell and the filling. The primary method for producing soft gelatin capsules is the rotary die method (RP Scherer), while the Globex system (Industrial Technologic Solutions Ltd) is an alternative for small volumes of round capsules. Soflet Gelcaps (Banner Pharmacaps) are tablets coated with a gelatin film.
Gelatin is also utilized for the microencapsulation of drugs, where the active drug is enclosed within a microsized capsule or beadlet, allowing it to be handled as a powder. The first microencapsulated drugs were fish oils and oily vitamins in gelatin beadlets prepared by coacervation.
Low-molecular-weight gelatin has been studied for its ability to enhance the dissolution of orally ingested drugs. Ibuprofen–gelatin micropellets have been developed for the controlled release of the drug. Other applications of gelatin include the preparation of pastes, pastilles, pessaries, and suppositories. Additionally, it serves as a tablet binder and coating agent, as well as a viscosity-increasing agent for solutions and semisolids.
Therapeutically, gelatin has been used in wound dressings and as a plasma substitute, although anaphylactoid reactions have been reported in the latter use. Absorbable gelatin is available in various forms, including sterile film, ophthalmic film, sterile sponge, sterile compressed sponge, and sterile powder from sponge. Gelatin sponge possesses hemostatic properties.
Gelatin is also widely used in food products and photographic emulsions.

Stability and Storage Conditions
Dry gelatin remains stable when exposed to air. Aqueous gelatin solutions are also stable for extended periods if stored in cool conditions, but they are prone to bacterial degradation. At temperatures above approximately 50°C, aqueous gelatin solutions may slowly depolymerize, leading to a reduction in gel strength upon resetting. Depolymerization accelerates at temperatures above 65°C, and gel strength can be halved if a solution is heated to 80°C for one hour. The rate and extent of depolymerization depend on the molecular weight of the gelatin, with lower-molecular-weight gelatin decomposing more quickly. Gelatin can be sterilized using dry heat. The bulk material should be stored in an airtight container in a cool, well-ventilated, and dry place.
Method of Manufacture

Gelatin is extracted from animal tissues rich in collagen, such as skin, sinews, and bones. While it is possible to extract gelatin using boiling water, it is more practical to pretreat the animal tissues with either acid or alkali. Gelatin obtained from the acid process is known as type A, whereas gelatin from the alkali process is referred to as type B.
The acid-conditioning process for producing type A gelatin is limited to soft bone ossein (demineralized bones), sinew, pigskin, calfskin, and fish skins to ensure sufficient yield. The material is cut into pieces and washed in cold water for a few hours to remove superficial fat. It is then treated with mineral acid solutions, mainly HCl or H2SO4, at a pH of 1 to 3 and a temperature of 15 to 20°C until maximum swelling occurs, which takes about 24 hours. The swollen stock is then washed with water to remove excess acid, and the pH is adjusted to 3.5 to 4.0 (for pigskin and fish skin) or 2.0 to 3.5 (for other tissues) for conversion to gelatin by hot-water extraction.
The hydrolytic extraction is performed in a batch process using successive portions of hot water at progressively higher temperatures (50 to 75°C) until the maximum yield of gelatin is obtained. The gelatin solution is then filtered through sterilized cellulose pads, deionized, concentrated to about 20 to 25% w/v, and sterilized by flashing it to 138°C for 4 seconds. The dry gelatin is formed by chilling the solution to create a gel, which is then air-dried in temperature-controlled ovens. The dried gelatin is ground to the desired particle size.
In the alkali process (liming), demineralized bones (ossein) or cattle skins are typically used. The animal tissue is immersed in a calcium hydroxide (2 to 5% lime) slurry for 2 to 4 months at 14 to 18°C. After liming, the stock is washed with cold water for about 24 hours to remove as much lime as possible. The stock solution is then neutralized with acid (HCl, H2SO4, H3PO4), and gelatin is extracted with water in a manner similar to the acid process, except the pH is maintained between 5.0 to 6.5 (neutral extraction).
During the preparation of bovine bones for gelatin production, specified risk materials that could contain transmissible spongiform encephalopathies (TSEs) vectors are removed. TSE infectivity is not present in pharmaceutical-grade gelatin.

Safety
Gelatin is extensively used in various pharmaceutical formulations, including both oral and parenteral products. Generally, when used in oral formulations, gelatin is considered a nontoxic and nonirritant material. However, there have been rare instances of gelatin capsules adhering to the esophageal lining, potentially causing local irritation. Hypersensitivity reactions, including serious anaphylactoid reactions, have been reported following the use of gelatin in parenteral products. There have been concerns about the potential spread of BSE/TSE infections through bovine-derived products. However, the risk of such contamination in medicines is extremely low.

LD50 (rat, oral): 5 g/kg
TDLo (mouse, IP): 700 mg/kg

Handling Precautions
Take standard precautions suitable for the situation and the amount of material being handled. It is recommended to wear eye protection and gloves. Gelatin should be managed in a well-ventilated area and kept away from ignition sources and heat. Empty containers can pose a fire hazard, so any gelatin residues should be evaporated under a fume hood.

Chemical-physical values

Test Item Unit Specification
Zinc
mg/kg
NMT 30
Iron
mg/kg
NMT 30
Arsenic (As)
mg/kg
NMT 1.0
Chromium (Cr)
mg/kg
NMT 2.0
Lead (PB)
mg/kg
NMT 1.5
Total Bacteria Count
CFU/g
NMT 1000
Total Mold and yeast
CFU/g
NMT 100
Escherichia Coli
in 1g
Negative
Salmonella
in 10g
Negative
Test Item Unit Specification
Viscosity drop
%
NMT 18
Mesh
mesh
NLT 8 & NMT 60
Transparency
mm
NLT 500
Loss on drying
%
NMT 14.0
Ashes
%
NMT 2.0
Heavy metal
mg/kg
NMT 30
Cadmium
mg/kg
NMT 0.5
Mercury
mg/kg
NMT 0.1
Copper
mg/kg
NMT 30

We look forward to your call with great anticipation.

Thank you for choosing Arvin Kala.